Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: Incidence, all-cause mortality and characteristics at diagnosis

Respirology

Volumn 17, Issue 5, 2012, Pages 861-868

  Amar, Rajeev K ^a,b   Jick, Susan S ^d   Rosenberg, Daniel ^c   Maher, Toby M ^e,f,g   Meier, Christoph R ^a,d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Novartis Pharma AG   (Switzerland)

^c ACTELION PHARMACEUTICALS LTD   (Switzerland)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

interstitial lung disease; lung damage; pulmonary toxicity; radiation induced effects; respiratory epidemiology

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC PROCEDURE; DRUG INDUCED INTERSTITIAL LUNG DISEASE; FEMALE; GASTROESOPHAGEAL REFLUX; GROUPS BY AGE; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HUMAN; HYPOTHYROIDISM; INCIDENCE; INCIDENTAL FINDING; INTERSTITIAL LUNG DISEASE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RADIATION INDUCED INTERSTITIAL LUNG DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; UNITED KINGDOM;

AGED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DRUG THERAPY; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 84862980804     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02187.x     Document Type: Article

References (24)

1. Camus P,. Drug-induced infiltrative lung diseases. In:, Schwarz MI, King TE Jr, (eds). Interstitial Lung Disease, 4th edn. Decker, Hamilton, 2003; 485-534.
2. Limper AH,. Chemotherapy-induced lung disease. Clin. Chest Med. 2004; 25: 53-64. (Pubitemid 38296331)
3. Foucher P, Martha BW,. 1997. Pneumotox Website. [Accessed 22 May 2012]. Last update V1.9 June 2011.
4. Benson MK, Bentley AM,. Lung disease induced by drug addiction. Thorax 1995; 50: 1125-7.
5. Wolff AJ, O'Donnell AE,. Pulmonary effects of illicit drug use. Clin. Chest Med. 2004; 25: 203-16. (Pubitemid 38296344)
6. Higenbottam TW,. Bronchiolitis obliterans following the ingestion of an Asian shrub leaf. Thorax 1997; 52 (Suppl 3): S68-72. (Pubitemid 27404975)
7. Abratt RP, Morgan GW, Silvestri G, et al,. Pulmonary complications of radiation therapy. Clin. Chest Med. 2004; 25: 167-77. (Pubitemid 38296341)
8. Thomeer MJ, Costabe U, Rizzato G, et al,. Comparison of registries of interstitial lung diseases in three European countries. Eur. Respir. J. Suppl. 2001; 32: 114s-8s. (Pubitemid 34755192)
9. Garcia Rodriquez L, Perez Gutthann S,. Use of the UK general practice research database for pharmacoepidemiology. Br. J. Clin. Pharmacol. 1998; 45: 419-25. (Pubitemid 28227341)
10. Gribbin J, Hubbard RB, Jeune IL, et al,. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-5. (Pubitemid 44787169)
11. Hansell A, Hollowell J, Nichols T, et al,. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999; 54: 413-9. (Pubitemid 29199779)
12. Camus P, Fanton A, Bonniaud P, et al,. Interstitial lung disease induced by drugs and radiation. Respiration 2004; 71 (4): 301-26. (Pubitemid 39179164)
13. Jick H, Jick SS, Derby LE,. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302: 766-8.
14. Jick H, Terris BZ, Derby LE, et al,. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol. Drug Saf. 1992; 1: 347-9.
15. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al,. Validity of the general practice research database. Pharmacotherapy 2003; 23: 686-9. (Pubitemid 36539051)
16. Hubbard R, Venn A, Lewis S, et al,. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am. J. Respir. Crit. Care Med. 2000; 161: 5-8. (Pubitemid 30055895)
17. Coultas DB, Zumwalt RE, Black WC, et al,. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 1994; 150: 967-72. (Pubitemid 24318021)
18. Karakatsani A, Papakosta D, Rapti A, et al,. Epidemiology of interstitial lung diseases in Greece. Respir. Med. 2009; 103: 1122-9.
19. Lõpez-Campos JL, Rodríguez-Becerra E,. Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. Eur. J. Epidemiol. 2004; 19: 155-61. (Pubitemid 38374566)
20. Demedts M, Wells AU, Antõ JM, et al,. Interstitial lung diseases: an epidemiological overview. Eur. Respir. J. Suppl. 2001; 32: 2s-16s. (Pubitemid 34755182)
21. Camus PH, Foucher P, Bonniaud PH, et al,. Drug-induced infiltrative lung disease. Eur. Respir. J. Suppl. 2001; 32: 93s-100s. (Pubitemid 34755189)
22. The NHS plan. A Plan for Investment. A Plan for Reform. Stationery Office, London. [Accessed 22 May 2012].
23. British Thoracic Society and Standards of Care Committee. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax 1999; 54 (Suppl 1): S1-S28.
24. American Thoracic Society, European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.